-
Stock Market News for Jan 11, 2011 - Market News
Tuesday, January 11, 2011 - 10:31am | 1081Fears of Portugal seeking a bailout package negatively affected the indices on Monday. However, prospects of strong earnings helped markets move back to a better position as they closed just slightly lower. The Dow fell 0.3% and closed at 11,637.45. The S&P 500 was down 0.1% and closed the...
-
Stryker Reports Stronger 4Q Than Expected
Tuesday, January 11, 2011 - 10:15am | 171JP Morgan has published a research report on Stryker Corporation (NYSE: SYK) after the company reported positive 4Q10 earnings results on Monday. In the report, JP Morgan writes "Stryker expects total 4Q revenues to come in at $1.995B (+8.8%), a full $50M above consensus and $30M ahead of our own $...
-
NUVA Amends 2011 Outlook, J.P. Morgan Reports
Tuesday, January 11, 2011 - 10:08am | 145Monday after the close, NuVasive, Inc. (NASDAQ: NUVA) announced preliminary 4Q results and once again amended its outlook for 2011 ahead of its upcoming presentation at the J.P.Morgan Healthcare conference (Tuesday at 11:30 a.m. EST). “Full year 2010 revenues are now expected to come in at $478M...
-
Stock Market News for Jan 11, 2011 - Market News
Tuesday, January 11, 2011 - 10:08am | 1081Fears of Portugal seeking a bailout package negatively affected the indices on Monday. However, prospects of strong earnings helped markets move back to a better position as they closed just slightly lower. The Dow fell 0.3% and closed at 11,637.45. The S&P 500 was down 0.1% and closed the...
-
Jefferies Remains Cautious On SYK
Tuesday, January 11, 2011 - 10:04am | 90Jefferies is remaining cautious on Stryker Corporation (NYSE: SYK) shares on the basis of “multiple challenging industry headwinds (procedure volumes, pricing, hospital capex, etc.), to which the company is highly exposed, coupled with a premium valuation.” “Our one-year price target is $61 (up...
-
Masimo To Negotiate Lower Royalties From COV Post 1Q11, Bets Citigroup
Tuesday, January 11, 2011 - 9:56am | 160Citigroup has published a research report on Masimo Corporation (NASDAQ: MASI) after the company encouraged the Street to remove COV's royalty stream post 1Q11, and Citi believes a lower royalty rate will most likely be negotiated. In the report, Citigroup writes "The covenant requires COV to pay...
-
Stifel Nicolaus Upgrades Stryker to Buy
Tuesday, January 11, 2011 - 9:47am | 18Stifel Nicolaus upgrades Stryker (NYSE: SYK) from Hold to Buy.
-
Citi Comments On Hospira, Give 2011 Outlook
Tuesday, January 11, 2011 - 8:58am | 220The recent lack of direction in Hospira (NYSE: HSP) shares has been attributed to a delayed Taxotere launch, but it views the shrinking P/E premium as a signal investors are growing wary of a potentially disappointing 2011 outlook and a 2012 “growth cliff.” Citi cut its 4Q EPS estimates for the...
-
Piper Jaffray Comments On Mindray Medical Following Management Meeting
Tuesday, January 11, 2011 - 8:42am | 196According to Piper Jaffray, Mindray Medical (NYSE: MR) management appeared quite confident in their "at least 16%" revenue growth guidance for 2011, although explicitly communicated the possibility of operating de-leverage due to increasing investment in S&M and R&D. Piper believes overall...
-
Jefferies Raises PT On Stryker Corporation
Tuesday, January 11, 2011 - 8:11am | 27Jefferies & Company has raised the price target on Stryker Corporation (NYSE: SYK) from $54 to $61 and maintains its Hold rating.
-
Jefferies Lowers PT On NuVasive
Tuesday, January 11, 2011 - 8:09am | 27Jefferies & Company has lowered the price target on NuVasive, Inc. (NYSE: NUVA) from $36 to $34 and maintains its Buy rating.
-
Wunderlich Raises PT On Stryker Corporation
Tuesday, January 11, 2011 - 8:01am | 27Wunderlich Securities has raised the price target on Stryker Corporation (NYSE: SYK) from $54 to $56 and maintains its Hold rating.
-
Oppenheimer Raises PT On Stryker Corporation
Tuesday, January 11, 2011 - 7:51am | 26Oppenheimer has raised the price target on Stryker Corporation (NYSE: SYK) from $57 to $61 and maintains its Outperform rating.
-
AngioDynamics Remains Neutral - Analyst Blog
Monday, January 10, 2011 - 7:01pm | 469We reiterate our Neutral recommendation for therapeutic and diagnostic devices maker AngioDynamics (ANGO). The company produced a mixed-bag in second-quarter fiscal 2011 with earnings beating the Zacks Consensus Estimate by a penny while revenues missing the forecast. Despite a modest decline in...
-
15 Low Priced Stocks to watch on the move (CRDC),(FXEN),(RDNT),MOSY) more below
Monday, January 10, 2011 - 6:41pm | 16315 LOW PRICED STOCKS ON THE MOVE,On the move (CRDC),(FXEN),(RDNT),MOSY),(PRWP),(LYSCF),(PSTI),(VSCP),(IMRS),(CERS),(OCZ),(VUTV),(CRME),(INAP),(CHTP)all look good Technically...BIG WINNERS FROM OUR LOW PRICED PICKS LAST NIGHT AND EARLY TODAY INCLUDE (SOL),(ZAGG),(ASTM),(GU)and (EEE) up 25% from...